Premium
When Nalanda Capital bet on Thyrocare Technologies Ltd in March, the private equity-style investor in public equities was likely...
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.